Hipertension y Riesgo Vascular最新文献

{"title":"Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles","authors":"Teresa Arrobas Velilla ,&nbsp;Carlos Guijarro ,&nbsp;Raquel Campuzano Ruiz ,&nbsp;Manuel Rodríguez Piñero ,&nbsp;José Francisco Valderrama Marcos ,&nbsp;Antonio Pérez Pérez ,&nbsp;Manuel Antonio Botana López ,&nbsp;Ana Morais López ,&nbsp;José Antonio García Donaire ,&nbsp;Juan Carlos Obaya ,&nbsp;Luis Castilla Guerra ,&nbsp;Vicente Pallares Carratalá ,&nbsp;Isabel Egocheaga Cabello ,&nbsp;Mercedes Salgueira Lazo ,&nbsp;María Mar Castellanos Rodrigo ,&nbsp;José María Mostaza Prieto ,&nbsp;Juan José Gómez Doblas ,&nbsp;Antonio Buño Soto ,&nbsp;en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular","doi":"10.1016/j.hipert.2022.12.002","DOIUrl":"https://doi.org/10.1016/j.hipert.2022.12.002","url":null,"abstract":"<div><p>Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 2","pages":"Pages 75-84"},"PeriodicalIF":0.6,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50180894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Importance of adherence in the management of hypertension","authors":"N. Martell Claros","doi":"10.1016/j.hipert.2022.06.002","DOIUrl":"10.1016/j.hipert.2022.06.002","url":null,"abstract":"<div><p>The WHO indicates that lack of adherence is a matter of the highest priority in Public Health, and is the main cause of not obtaining all the benefits that medications can provide; it is at the origin of medical and psychosocial complications; reduces quality of life; it increases the probability of the appearance of drug resistance and wastes healthcare resources.</p><p>The no adherence prevalence in hypertension (HTN) ranges between 55.5% with self-reporting and 46.6% with pill counting, and treatment abandonment occurs in 18.5% of patients.</p><p>The electronic prescription has been validated in HTN using MEMS as a comparison, with sensitivity of 87% and specificity of 93.7%, with an area under the curve of 0.903.</p><p>In 2019, almost 10 million deaths were directly attributed to HTN. No other disease causes as high a number of deaths and has as high a projected increase in deaths as cardiovascular disease (CVD). By 2030, it is projected that more than 22 million people/year will die from CVD, almost 5 million more than in 2012.</p><p>In a predictive model for a period of 10 years in five European countries (Italy, Germany, France, Spain and England), the potential savings of increasing adherence to antihypertensive treatment to 70% has been estimated at 332 million euros (80 million in the case of Spain).</p><p>The use of fixed combinations of two or three drugs is a good method to reduce non-adherence.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 34-39"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9462316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Indicaciones de fundoscopia en pacientes con presión arterial elevada en la sala de urgencias","authors":"J. Galvez-Olortegui ,&nbsp;R. Bouchikh-El Jarroudi ,&nbsp;L. Camacho-Saavedra ,&nbsp;C. Burgueño-Montañes","doi":"10.1016/j.hipert.2022.11.003","DOIUrl":"https://doi.org/10.1016/j.hipert.2022.11.003","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 48-50"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50186249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abordaje terapéutico integral de la hipertensión arterial. Recomendaciones para Centroamérica y el Caribe","authors":"F. Wyss ,&nbsp;O. Valdez ,&nbsp;M. Camafort ,&nbsp;A. Coca","doi":"10.1016/j.hipert.2022.05.004","DOIUrl":"https://doi.org/10.1016/j.hipert.2022.05.004","url":null,"abstract":"<div><p>Latin American hypertension guidelines, tailored to the needs of countries of Central and South America, should be applied and known by most Latin American physicians. The knowledge and implementation of the Guidelines is one of the greatest challenges of hypertension societies in Latin America such as the Central American and Caribbean Society of Arterial Hypertension (SCCH), the Latin American Society of Hypertension (LASH) and the Inter-American Society of Cardiology (SIAC).</p><p>In 2020, the Inter-American Society of Cardiology (SIAC) published its position on the current Guidelines for Arterial Hypertension due to the need to standardize the evaluation, diagnosis, treatment and control of hypertension, establishing recommendations that should be adopted in all Latin American countries, aimed at optimizing the management of cardiovascular risk and achieving a substantial improvement in the reduction of cardiovascular events and mortality.</p><p>This document intends to reinforce all proposals by the LASH guidelines and the position of the SIAC in relation to the therapeutic approach and pharmacological recommendations for patients with hypertension (HT), in order to achieve better HT control in the Central American and Caribbean area, and the consequently prognosis improvement of cardiovascular disease in the area.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 40-47"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50186250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SINDROME NEFROTICO Y EMBARAZO","authors":"Alfonso Otero González","doi":"10.1016/j.hipert.2022.12.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2022.12.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 1-4"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50185833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neuroimaging in small vessel disease","authors":"L. Mena Romo,&nbsp;M. Gómez-Choco","doi":"10.1016/j.hipert.2022.05.005","DOIUrl":"10.1016/j.hipert.2022.05.005","url":null,"abstract":"<div><p>The objective of this article is to review the literature on neuroimaging in small vessel disease. A review was carried out through the Pubmed search engine, without a filter of years, using terms such as: cerebral small vessel disease; white matter hyperintensity; brain microbleed; WBC. Small vessel disease is the most common vascular pathology. Its basis is in the affectation of the small cerebral vessels that eventually causes an alteration in the blood–brain barrier. Its clinical implication is highly relevant. Using magnetic resonance imaging, different expressions of the disease have been observed, such as white matter hyperintensities, microbleeds or lacunar infarcts. Other more recent techniques, such as brain blood flow measurements, are helping to increase understanding of the pathophysiology of this disease.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 25-33"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9087817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carotid intima media thickness (CIMT) in adults in the AWI-Gen Nairobi site study: Profiles and predictors","authors":"S.F. Mohamed ,&nbsp;C. Khayeka-Wandabwa ,&nbsp;S. Muthuri ,&nbsp;N.N. Ngomi ,&nbsp;C. Kyobutungi ,&nbsp;T.N. Haregu","doi":"10.1016/j.hipert.2022.08.001","DOIUrl":"10.1016/j.hipert.2022.08.001","url":null,"abstract":"<div><h3>Background</h3><p>Carotid intima media thickness (CIMT) is used as a marker of subclinical and asymptomatic atherosclerotic vascular disease. Increased CIMT is associated with future cerebrovascular and cardiovascular events. There is limited data on the profile and correlates of CIMT in Africa. The aim of this study was to describe the profile and correlates of CIMT in apparently normal younger-age adults in an urban setting in Kenya.</p></div><div><h3>Methods</h3><p>This study used population-based data collected from 2003 adults between the ages of 40 and 60 years in two slums of Nairobi as part of a genetic study. CIMT was measured using LOGIQ e (GE Healthcare, CT, USA) ultrasound on both left and right carotid arteries, whereby maximum, mean, and minimum values were recorded. Age- and sex-specific CIMT measurements were calculated and their association with basic sociodemographic, behavioral and body composition indicators were investigated.</p></div><div><h3>Results</h3><p>The median (IQR) CIMT were 0.58 (0.51, 0.66) and 0.59 (0.53, 0.66) in men and women, respectively. About 16% of the study population had CIMT greater than 0.7<!--> <!-->mm, the cut off for higher CIMT. Nearly 60% had CIMT values ≥75th percentile. Age, current use of alcohol, systolic blood pressure, subcutaneous fat thickness, pulse rate and pulse pressure were found to be the main predictors of CIMT in our study population.</p></div><div><h3>Conclusion</h3><p>This study provided population-based reference values and predictors for CIMT for an adult population living in urban poor settings in Kenya. Future studies need to consider biochemical and genetic predictors of CIMT in this population.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 5-15"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9462792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fármacos antihipertensivos, ¿por la mañana o por la noche?","authors":"","doi":"10.1016/j.hipert.2022.11.001","DOIUrl":"10.1016/j.hipert.2022.11.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 51-53"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47538951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Síndrome nefrótico secundario a preeclampsia: presentación, manejo y evolución clínica observados en 5 años de experiencia","authors":"A.M. Ghelfi ,&nbsp;F. Garavelli ,&nbsp;B. Meres ,&nbsp;F.R. Dipaolo ,&nbsp;M.N. Lassus ,&nbsp;A.L. Pahud ,&nbsp;M. Vazquez ,&nbsp;J.G. Kilstein ,&nbsp;R.F. Mamprin D’Andrea","doi":"10.1016/j.hipert.2022.05.008","DOIUrl":"https://doi.org/10.1016/j.hipert.2022.05.008","url":null,"abstract":"<div><h3>Introduction</h3><p>Nephrotic syndrome (NS) is rare during pregnancy. The main cause is severe pre-eclampsia (PR). Our aim was to describe the clinical presentation, analytical features, medical management, and progress of women with NS due to PE.</p></div><div><h3>Materials and methods</h3><p>A descriptive, retrospective study, conducted from 01/01/2017 to 01/01/2022 (5<!--> <!-->years). Women with a gestational age (GA) ≥<!--> <!-->20<!--> <!-->weeks were included in the study, hospitalised due to hypertensive disorders in pregnancy (HDP), with no evidence of kidney damage prior to gestation.</p></div><div><h3>Results</h3><p>Of the 652 HDP, 452 PE and 21 NS were identified. Maternal age was 25<!--> <!-->±<!--> <!-->5.7 years, GA at diagnosis was 33.1<!--> <!-->±<!--> <!-->5.1 weeks. All the women had facial and peripheral oedema: 5 pleural effusion, 3 pericardial effusion, and 2 anasarca. Their p24 was 6.17<!--> <!-->±<!--> <!-->2.34<!--> <!-->grams (3.10-10.8), serum albumin 2.5<!--> <!-->±<!--> <!-->0.27<!--> <!-->g/dL (2.10-2.90), and serum cholesterol 281.4<!--> <!-->±<!--> <!-->21.7<!--> <!-->mg/dL (251-316). Thirteen developed maternal complications: acute kidney damage, pulmonary oedema, dilated cardiomyopathy, eclampsia, and HELLP syndrome. They all remained hypertensive postpartum, and required a combination of two to three antihypertensive drugs. They all received statins postpartum, and angiotensin converting enzyme (ACE) inhibitors to manage proteinuria. None developed hyperkalaemia or creatinine elevation. Hospital stay was 10.4<!--> <!-->±<!--> <!-->3.7<!--> <!-->days. All nephrotic range proteinuria parameters reversed prior to discharge. No deaths were recorded.</p></div><div><h3>Conclusion</h3><p>Presentation ranged from peripheral oedema to serous involvement. Severity of proteinuria varied. Use of ACE inhibitors did not precipitate hyperkalaemia or kidney failure. Maternal complications were frequent, but no deaths were recorded.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 1","pages":"Pages 16-24"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50185832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"RESUMENES","authors":"","doi":"10.1016/j.hipert.2022.07.001","DOIUrl":"10.1016/j.hipert.2022.07.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"39 4","pages":"Pages 198-200"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44542007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}